Latest News and Press Releases
Want to stay updated on the latest news?
-
BERKELEY, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), today announced that Ryan Spencer, Senior Vice President, Commercial, and Interim Co-President,...
-
MONROE TOWNSHIP, N.J., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NASDAQ: OPTT), a leader in innovative and cost-effective ocean energy solutions,...
-
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Syapse, a company accelerating precision medicine through insights derived from its global health system network, today announced that Fletcher...
-
MONTRÉAL, 27 août 2019 (GLOBE NEWSWIRE) -- L'Association québécoise des technologies (AQT) est fière de dévoiler les 9 entreprises finalistes de l’édition 2019 du concours « PME en...
-
Bain Capital Life Sciences Managing Director brings extensive capital markets and diverse life sciences industry experience EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Dynavax...
-
EMERYVILLE, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and...
-
EMERYVILLE, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and...
-
Second quarter 2019 HEPLISAV-B® net product revenue of $8.3 millionUpdated net product revenue guidance of $32-$36 million for full year 2019Conference call to be held today at 4:30 p.m. ET/1:30 p.m....
-
SALT LAKE CITY, July 29, 2019 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) today provided a business update. The update provides a broad overview of SINTX Technologies, Inc. (“the...
-
BERKELEY, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on developing novel vaccines, will report...